Therefore, this study documents a novel TBK1 inhibitor, which serves as a potential therapeutic target for autoimmune diseases, and elucidated a significant function for MAP4K1 linked to innate immunity and subsequent adaptive immunity. The gene discussed is TBK1; the disease is autoimmune disease.